Search

Search Results
Results 25911 - 25920 of 26181 for AIDS
  • News - 16 Feb 2010
    AGA Medical Holdings, a leading developer of interventional medical devices for the minimally invasive treatment of structural heart defects and vascular abnormalities, today reported financial...
  • News - 25 May 2004
    HHS Secretary Tommy G. Thompson today announced $498 million in awards to states, territories and four major metropolitan areas to strengthen the ability of hospitals and other health care facilities...
  • Drug - 15 Apr 2025
    Consumer Medicine Information (CMI) about Kaletra intended for persons living in Australia.
  • Drug - 14 Apr 2025
    Consumer Medicine Information (CMI) about Kisqali intended for persons living in Australia.
  • Drug - 10 Apr 2025
    Consumer Medicine Information (CMI) about Rivaxib intended for persons living in Australia.
  • Drug - 2 Apr 2025
    Consumer Medicine Information (CMI) about Axit intended for persons living in Australia.
  • Drug - 25 Mar 2025
    Consumer Medicine Information (CMI) about Fasenra Pen intended for persons living in Australia.
  • Drug - 6 Mar 2025
    Consumer Medicine Information (CMI) about Imanib intended for persons living in Australia.
  • Drug - 5 Mar 2025
    Consumer Medicine Information (CMI) about Demazin Original Cold + Flu Relief Day + Night Tablets intended for persons living in Australia.
  • Drug - 26 Feb 2025
    Consumer Medicine Information (CMI) about Talzenna intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.